RARE AND NOVEL KIAA1549-BRAF FUSION BREAKPOINTS PREDICT POOR CLINICAL OUTCOME FOR PATIENTS WITH RECURRENT OR PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA: PHASE II PNOC001 TRIAL RESULTS

Waszak, Sebastian MartinAboian, MariamMinturn, JaneLeary, SarahAbdelbaki, Mohamed S.Goldman, StewartElster, JenniferKraya, AdamLueder, MatthewRamakrishnan, Divyavon Reppert, MarcLiu, KevinResnick, AdamSolomon, DavidMolinaro, AnnettePhillips, JoannaPrados, MichaelHaas-Kogan, DaphneMueller, Sabine2024-02-232024-02-232024-02-232023-11-01https://infoscience.epfl.ch/handle/20.500.14299/205189WOS:001115245400342Life Sciences & BiomedicineRARE AND NOVEL KIAA1549-BRAF FUSION BREAKPOINTS PREDICT POOR CLINICAL OUTCOME FOR PATIENTS WITH RECURRENT OR PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA: PHASE II PNOC001 TRIAL RESULTStext::conference output::conference proceedings::conference paper